Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Countdown to the High-NA Lithography Era! ASML Holding NV ADR (ASML.US) announced that the first batch of chips will be available in a few months. HBM/DRAM collaborates with AI chips to welcome the process node transition.
US Stock Market Move | Q1 profits surged nearly 80%, RERE.US surged over 11% in early trading.
Wealth Bank: Most of the strongest stock market up days in the US occur during bear markets. Investors who "time the market" accurately may miss out on the market.
Countdown to the High-NA Lithography Era! ASML Holding NV ADR (ASML.US) announced that the first batch of chips will be available in a few months. HBM/DRAM collaborates with AI chips to welcome the process node transition.
US Stock Market Move | Q1 profits surged nearly 80%, RERE.US surged over 11% in early trading.
Wealth Bank: Most of the strongest stock market up days in the US occur during bear markets. Investors who "time the market" accurately may miss out on the market.
